VINCERX PHARMA, INC.

Analyst Reco. Vincerx Pharma, Inc.

Equities

VINC

US92731L1061

Market Closed - Nasdaq Other stock markets 04:00:00 2024-06-07 pm EDT			5-day change	1st Jan Change
0.712 ^USD	-1.26%		+12.84%	-39.66%

Apr. 26	Tech Rally Boosts Exchange-Traded Funds, Equity Futures Pre-Bell Friday	MT
Apr. 26	Vincerx Pharma Prices Public Offering of Shares, Warrants	MT

Analyst Reco.

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Chardan Trims Price Target on Vincerx Pharma to $3 From $4, Keeps Buy Rating	22-11-17	MT
SVB Securities Adjusts Vincerx Pharma's Price Target to $5 From $6, Keeps Outperform Rating	22-08-12	MT
Cantor Fitzgerald Adjusts Vincerx Pharma's Price Target to $8 From $22, Reiterates Overweight Rating	22-06-08	MT
Chardan Cuts Price Target on Vincerx Pharma to $4 From $11 as it Shifts VIP152 Launch to 2026 From 2024 Reiterates Buy Rating	22-06-07	MT
SVB Securities Adjusts Vincerx Pharma's Price Target to $6 From $19, Keeps Outperform Rating	22-06-07	MT
B. Riley Adjusts Vincerx Pharma Price Target to $6 From $12, Maintains Buy Rating	22-06-07	MT
Chardan Cuts Price Target on Vincerx Pharma to $4 From $11 on Adjusted VIP152 Estimates, Reiterates Buy Rating	22-06-07	MT
Chardan Lowers Vincerx Pharma's Price Target to $11 From $14, Buy Rating Kept	22-05-13	MT
B. Riley Lowers Vincerx Pharma's Price Target to $12 from $26, Says May Need to Raise Additional Capital Under Unfavorable Conditions; Keeps Buy Rating	22-04-12	MT
SVB Leerink Adjusts Vincerx Pharma's Price Target to $20 from $24, Keeps Outperform Rating	22-03-30	MT
HC Wainwright Adjusts Vincerx Pharma's Price Target to $28 From $25, Reiterates Buy Rating	22-03-30	MT
HC Wainwright Starts Vincerx Pharma at Buy With $25 Price Target	22-01-14	MT
Cantor Fitzgerald Starts Vincerx Pharma at Overweight With $25 Price Target	21-12-23	MT
SVB Leerink Starts Vincerx Pharma at Outperform with $24 Price Target	21-11-01	MT
VINCERX PHARMA : Laidlaw & Co. Starts Vincerx Pharma at Buy with $30 Price Target	21-09-13	MT
VINCERX PHARMA : B. Riley Starts Vincerx Pharma at Buy with $26 PT, Says Shares Offer 'Attractive' Entry Point Ahead of VIP152 Clinical Updates; Keeps Buy Rating	21-08-25	MT
VINCERX PHARMA : Chardan Adjusts Price Target on Vincerx to $30 From $33, Citing 'Forward OpEx Estimates, Recent Dilution;' Buy Rating Kept	21-08-13	MT
VINCERX PHARMA : Chardan Starts Vincera Pharma at Buy With $33 Price Target	21-01-06	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

As early as today, start finding the best investment opportunities!

Optimize my profits

fermer